Michigan Tech College of Engineering Distinguished Speakers Series
"New Frontiers in the Pharmaceutical and Medical Sciences: Advanced Intelligent Hydrogels for Treatment of Diabetes, Cancer and Multiple Sclerosis"
Nicholas A. Peppas, Sc.D.
Fletcher Stuckey Pratt Chair in Engineering
Professor of Biomedical Engineering, Chemical Engineering and Pharmacy
Chairman, Biomedical Engineering Department
Director of Center on Biomaterials, Drug Delivery, and Bionanotechnology
The University of Texas at Austin
Engineering the molecular design of intelligent hydrogels by controlling recognition and specificity is the first step in coordinating and duplicating complex biological and physiological processes. We address design and synthesis characteristics of nover crosslinked networks capable of protein release as well as artificial molecular structures capable of specific molecular recognition of biological molecules. Recent developments in protein delivery have been directed towards the preparation of targeted formulations for protein delivery to specific sites, use of environmentally-responsive polymers to achieve pH- or temperature-triggered delivery, usually in modulated mode, and improvement of the behavior of their mucoadhesive behavior and cell recognition. Molecular imprinting and microimprinting techniques, which create stereo-specific three-dimensional binding cavities based on a biological compound of interest can lead to preparation of biomimetic materials for intelligent drug delivery, drug targeting, and tissue engineering. We have been successful in synthesizing novel glucose-binding molecules based on non-covalent directed interactions formed via molecular imprinting techniques within aqueous media.
Nicholas A. Peppas is the Fletcher S. Pratt Chaired Professor in the Departments of Chemical, Biomedical Engineering and Pharmacy, and Chairman of the Department of Biomedical Engineering of the University of Texas at Austin. Peppas is a world leader in biomaterials, polymer physics, drug delivery and bionanotechnology. The multidisciplinary approach of his research blends modern molecular and cellular biology with engineering to generate the next-generation of medical systems and devices for patient treatment. He set the fundamentals and rational design of drug delivery systems over the past forty years and developed models of drug and protein diffusion in controlled release devices and biological tissues. In 2012 he received the Founders Award of the National Academy of Engineering, the highest recognition of the Academy, for these contributions to the field. Peppas is a member of the Institute of Medicine of the National Academies, the National Academy of Engineering, the National Academy of France, the Royal Academy of Pharmacy of Spain, and the Academy of Texas. He has been recognized with awards from AIChE (Founders Award, William Walker Award, Institute Lecture, Jay Bailey Award, Bioengineering Award, Materials Award), the Biomedical Engineering Society (Distinguished Scientist Award), the American Institute of Medical and Biological Engineering (Galletti Award), the Society for Biomaterials (Founders, Clemson and Hall Awards), the Controlled Release Society (Founders, Heller and Eurand Awards) and other societies. In 2008, AIChE named him on of the One Hundred Chemical Engineers of the Modern Era. He is President of the International Union of Societies of Biomaterials Science and Engineering, and Past-Chair of the Council of BME Chairs. Previously, he served as President of SFB and the Controlled Release Society. He is a fellow of AAAS, AIChE, APS, ACS, MRS, SFB, BMES, AIMBE, CRS, AAPS, and ASEE. He is a highly cited scientist (50,000 citations, H=110) and has supervised the research of 95 PhDs and about 180 postdocs and graduate students. Peppas holds a Dipl. Eng. from the NTU of Athens (1971), a Sc.D. from MIT (1973), and honorary doctorates from the Universities of Ghent, Parma, Athens and Ljubljana.
A Venture in Africa; Pavlis Institute Scholars in Ghana[Katie Dobbin, Tim Veverica, Jess Banda] Presented at the 4th Annual D80 Conference, "a celebration of our efforts to solve issues that confront the world's poorest 80%. Together we are creating a better future." October 9, 2010, at Michigan Technological University.
More info: mtu.edu/d80/
Michigan Technological University is doing a study in conjunction with Portage Health and the Gerber Fountain about how tears can be used as an alternative to using blood samples to test infant nutrition.
"This research could change infant care and ensure the well-being of the youngest members of our society," Adrienne R. Minerick, Ph.D., Michigan Tech.
Information on the study is available on the video below. If you or someone you know has an infant, and would be willing to participate in the study, contact your Portage Health Pediatrician at (906) 483-1700, or Minerick at (906) 487-2796 or firstname.lastname@example.org.